Next Century Growth Investors’s Gilead Sciences GILD Stock Holding History

Next Century Growth Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,700	Closed	-$1.47M	–	128
2020 Q1	$1.47M	Buy	+19,700	New	+$1.36M	0.24%	101
2015 Q4	–	Sell	-28,246	Closed	-$2.77M	–	179
2015 Q3	$2.77M	Sell	28,246 -257	-0.9%	-$28.5K	0.12%	146
2015 Q2	$3.34M	Buy	28,503 +8,457	+42%	+$924K	0.11%	170
2015 Q1	$1.97M	Sell	20,046 -9,700	-33%	-$985K	0.07%	182
2014 Q4	$2.8M	Sell	29,746 -27,637	-48%	-$2.86M	0.1%	162
2014 Q3	$6.11M	Sell	57,383 -39,347	-41%	-$3.85M	0.22%	121
2014 Q2	$8.02M	Sell	96,730 -35,851	-27%	-$2.79M	0.26%	112
2014 Q1	$9.39M	Buy	132,581 +21,855	+20%	+$1.71M	0.28%	94
2013 Q4	$8.32M	Buy	110,726 +789	+0.7%	+$54.9K	0.23%	121
2013 Q3	$6.91M	Sell	109,937 -1,411	-1%	-$84.3K	0.2%	129
2013 Q2	$5.7M	Buy	+111,348	New	+$5.8M	0.18%	125

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Next Century Growth Investors's GILD Position: Q2 2020 in Review

Next Century Growth Investors sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 19,700 shares — an estimated $1.47M sold.

Next Century Growth Investors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $9.39M in Q1 2014. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Next Century Growth Investors reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Next Century Growth Investors sold 19,700 Gilead Sciences shares in Q2 2020, an estimated $1.47M.
Next Century Growth Investors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Next Century Growth Investors's Gilead Sciences position peaked at $9.39M in Q1 2014.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Next Century Growth Investors's 13F filing for Q2 2020, filed 14 Aug 2020.